Literature DB >> 9259215

Pregnancy-related mortality surveillance--United States, 1987-1990.

L M Koonin1, A P MacKay, C J Berg, H K Atrash, J C Smith.   

Abstract

PROBLEM/CONDITION: The Healthy People 2000: National Health Promotion and Disease Prevention Objectives specifies goals of no more than 3.3 maternal deaths per 100,000 live births overall and no more than 5.0 maternal deaths per 100,000 live births among black women; as of 1990, these goals had not been met. In addition, race-specific differences between black women and white women persist in the risk for pregnancy-related death. REPORTING PERIOD COVERED: This report summarizes surveillance data for pregnancy-related deaths in the United States for 1987-1990. DESCRIPTION OF SYSTEM: The National Pregnancy Mortality Surveillance System was initiated in 1988 by CDC in collaboration with the CDC/American College of Obstetricians and Gynecologists Maternal Mortality Study Group. Health departments in the 50 states, the District of Columbia, and New York City provided CDC with copies of death certificates and available linked outcome records (i.e., birth certificates or fetal death records) of all identified pregnancy-related deaths.
RESULTS: During 1987-1990, 1,459 deaths were determined to be pregnancy-related. The overall pregnancy-related mortality ratio was 9.2 deaths per 100,000 live births. The pregnancy-related mortality ratio for black women was consistently higher than for white women for every risk factor examined by race. The disparity between pregnancy-related mortality ratios for black women and white women increased from 3.4 times greater in 1987 to 4.1 times greater in 1990. Older women, particularly women aged > or =35 years, were at increased risk for pregnancy-related death. The gestational age-adjusted risk for pregnancy-related death was 7.7 times higher for women who received no prenatal care than for women who received "adequate" prenatal care. The distribution of the causes of death differed depending on the pregnancy outcome; for women who died following a live birth (i.e., 55% of the deaths), the leading causes of death were pregnancy-induced hypertension complications, pulmonary embolism, and hemorrhage.
INTERPRETATION: Pregnancy-related mortality ratios for black women continued, as noted in previously published surveillance reports, to be three to four times higher than those for white women. The risk factors evaluated in this analysis confirmed the disparity in pregnancy-related mortality between white women and black women, but the reason(s) for this difference could not be determined from the available information. ACTIONS TAKEN: Continued surveillance and additional studies should be conducted to assess the magnitude of pregnancy-related mortality, to identify those differences that contribute to the continuing race-specific disparity in pregnancy-related mortality, and to provide information that policy makers can use to develop effective strategies to prevent pregnancy-related mortality for all women.

Entities:  

Mesh:

Year:  1997        PMID: 9259215

Source DB:  PubMed          Journal:  MMWR CDC Surveill Summ


  15 in total

Review 1.  Stress, adverse pregnancy outcomes, and African-American females.

Authors:  Ivor Lensworth Livingston; Jane A Otado; Carmen Warren
Journal:  J Natl Med Assoc       Date:  2003-11       Impact factor: 1.798

2.  Safe motherhood in the United States: challenges for surveillance.

Authors:  Trude A Bennett; Melissa M Adams
Journal:  Matern Child Health J       Date:  2002-12

3.  The Pregnancy Risk Assessment Monitoring System (PRAMS): methods and 1996 response rates from 11 states.

Authors:  B C Gilbert; H B Shulman; L A Fischer; M M Rogers
Journal:  Matern Child Health J       Date:  1999-12

Review 4.  Angiogenic factors in preeclampsia: potential for diagnosis and treatment.

Authors:  Arvind Goel; Sarosh Rana
Journal:  Curr Opin Nephrol Hypertens       Date:  2013-11       Impact factor: 2.894

5.  Changes in the health status of women during and after pregnancy.

Authors:  Jennifer S Haas; Rebecca A Jackson; Elena Fuentes-Afflick; Anita L Stewart; Mitzi L Dean; Phyllis Brawarsky; Gabriel J Escobar
Journal:  J Gen Intern Med       Date:  2005-01       Impact factor: 5.128

6.  Hypertensive Disorders of Pregnancy - A Life-Long Risk?!

Authors:  C E Schausberger; V R Jacobs; G Bogner; P Wolfrum-Ristau; T Fischer
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-01       Impact factor: 2.915

Review 7.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

8.  Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia.

Authors:  W T Schnettler; D Dukhovny; J Wenger; S Salahuddin; S J Ralston; S Rana
Journal:  BJOG       Date:  2013-05-07       Impact factor: 6.531

9.  Pregnancy-induced hypertension, but not gestational diabetes mellitus, is a risk factor for venous thromboembolism in pregnancy.

Authors:  Hyun Sun Won; Do Yi Kim; Moon Seok Yang; Sung Ja Lee; Hyun-Ho Shin; Jeong Bae Park
Journal:  Korean Circ J       Date:  2011-01-31       Impact factor: 3.243

10.  Cesarean section rates and indications in sub-Saharan Africa: a multi-country study from Medecins sans Frontieres.

Authors:  Kathryn Chu; Hilde Cortier; Fernando Maldonado; Tshiteng Mashant; Nathan Ford; Miguel Trelles
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.